Shimadzu FIF
VC Fund
Kyoto, Japan
Shimadzu FIF is a Corporate Venture Capital arm of Shimadzu
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Shimadzu FIF invests in
Stages Shimadzu FIF invests in
Countries Shimadzu FIF invests in
Round sizes
Round size
- Seed
- $1.3M–$1.3M
- Series A
- $9M–$12M
Investment Focus
Industry
- Biotechnology 2 (25%)
- Medical Device 2 (25%)
- Hardware 1 (13%)
- Software 1 (13%)
- 3D Printing 1 (13%)
Stage
- Series A 2 (25%)
- Seed 1 (13%)
- Series B 1 (13%)
- Series C 1 (13%)
- Series D 1 (13%)
Country
- Japan 4 (50%)
- United States 2 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware. | $3.5M / Series B / Feb 17, 2026 | ||
| Immunological is a developer of electrochemical measurement devices intended to evaluate biomarkers such as genes, proteins, and cell signals using electrode reactions.. The company's product uses disposable printable electrodes in its sensors, thereby providing health-care experts with accurate analysis and measurements in their diagnosis andfood safety inspection tests. | Venture - Series Unknown / Nov 14, 2025 | ||
| SUN METALON aims to create a world where metal products can be produced from local ores. The company was founded in 2021 and is headquartered in Redondo Beach, California. | $9M / Series A / May 21, 2025 | ||
| Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and fiveyears of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster. | $12M / Series A / Mar 19, 2025 | ||
| Rhinoflux is an energy management company that develops efficient thermal management technologies for advanced cooling systems. | $1.3M / Seed / Oct 30, 2024 | ||
| RUTILEA is an IT company that aims to solve social issues through open-source. By advancing revolutionary 'AI teaching AI' concept, edefine automation, data-driven decision-making, and operational efficiency. | $58.6M / Series D / Sep 02, 2024 | ||
| RUTILEA is an IT company that aims to solve social issues through open-source. By advancing revolutionary 'AI teaching AI' concept, edefine automation, data-driven decision-making, and operational efficiency. | Series C / Nov 15, 2023 | ||
| See all 8 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Shimadzu FIF invest in?
Shimadzu FIF invests primarily in Biotechnology, Medical Device and Hardware startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Shimadzu FIF's check size?
Shimadzu FIF typically joins rounds of $1.3M–$1.3M at Seed and $9M–$12M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shimadzu FIF participates in.
When did Shimadzu FIF last invest?
The most recent investment recorded for Shimadzu FIF closed in Feb 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
